These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12683388)

  • 1. [The significance of the list of prescribable drugs (so-called positive list) for psychopharmacotherapy].
    Fritze J; Schmauss M; Holsboer F;
    Nervenarzt; 2003 Feb; 74(2):195-7. PubMed ID: 12683388
    [No Abstract]   [Full Text] [Related]  

  • 2. [Legal boundaries of negative and positive lists].
    Arndt M
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):630-2. PubMed ID: 9527457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Off-label use in psychopharmacotherapy. Letter to Federal Minister Ulla Schmidt, Pulheim, 22 January 2003].
    Fritze J
    Nervenarzt; 2003 Apr; 74(4):389; discussion 390. PubMed ID: 12800838
    [No Abstract]   [Full Text] [Related]  

  • 4. [Open letter to minister of health. Toad medicine].
    Erdmann E
    Krankenpfl J; 2003; 41(4-6):110-1. PubMed ID: 12929321
    [No Abstract]   [Full Text] [Related]  

  • 5. [Legal decisions of german supreme courts about prescription of drugs for not registered indications ("off-label-use")].
    Wetterling T
    Fortschr Neurol Psychiatr; 2004 May; 72(5):255-9. PubMed ID: 15136946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vascular specialists in a campaign against positive list. Threat of deficient care for 4.5 million vascular patients].
    Krankenpfl J; 2003; 41(4-6):120. PubMed ID: 12929329
    [No Abstract]   [Full Text] [Related]  

  • 7. [Positive list of drugs and osteoporosis].
    Krankenpfl J; 2003; 41(4-6):113. PubMed ID: 12929324
    [No Abstract]   [Full Text] [Related]  

  • 8. [Off-label prescriptions. Drug use outside of established guidelines and treatment standard].
    Weissbach L; Boedefeld EA
    Urologe A; 2003 Mar; 42(3):428-32. PubMed ID: 12723544
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prescribing fictitiously approved drugs: regress threatens!].
    Walbert H
    MMW Fortschr Med; 2012 Apr; 154(6):10. PubMed ID: 22642016
    [No Abstract]   [Full Text] [Related]  

  • 10. [Psychopharmacological regulations. Results and commentary to the report on drug regulations 2002].
    Fritze J
    Nervenarzt; 2003 Mar; 74(3):301-6. PubMed ID: 12722759
    [No Abstract]   [Full Text] [Related]  

  • 11. [Does red-green destroy phytotherapy?].
    Krankenpfl J; 2003; 41(4-6):111. PubMed ID: 12929322
    [No Abstract]   [Full Text] [Related]  

  • 12. [The physician caught between two chairs. Comments on the difficulty in dealing with off-label use].
    Harder Yv
    Urologe A; 2007 Oct; 46(10):1429-34. PubMed ID: 17786403
    [No Abstract]   [Full Text] [Related]  

  • 13. [Off-label use of drugs--the legal framework].
    Koyuncu A
    Dtsch Med Wochenschr; 2012 Jul; 137(30):1519-23. PubMed ID: 22869512
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prerequisites in prescribing practice: physician decision processes].
    Dierks C
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):620-4. PubMed ID: 9527454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Negative lists and positive lists--health policy aspects].
    Huber E
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):624-7. PubMed ID: 9527455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of the German Act on the Reform of the Market for Medicinal Products for psychopharmacotherapy].
    Gründer G
    Nervenarzt; 2016 Apr; 87(4):356-66. PubMed ID: 26983820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CNS drugs approved by the centralised European procedure: true innovation or dangerous stagnation?
    Barbui C; Cipriani A; Lintas C; Bertelé V; Garattini S
    Psychopharmacology (Berl); 2007 Feb; 190(2):265-8. PubMed ID: 17119928
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prescription of drugs without registered indication].
    Wetterling T
    Fortschr Neurol Psychiatr; 2004 May; 72(5):245-54. PubMed ID: 15136945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expert evaluation of private drug prescriptions].
    Kreck C; Saller R
    Gesundheitswesen; 1995 May; 57(5):258-63. PubMed ID: 7620245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The rheumatologist's conflict between "off-label" prescription and failure to render assistance].
    Hellmich B; Gross WL
    Z Rheumatol; 2003 Feb; 62(1):34-5. PubMed ID: 12624800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.